Defining and managing overactive bladder: Disagreement among the experts

Urology

Volumn 81, Issue 2, 2013, Pages 257-262

  Lee, Una J ^a   Scott, Victoria C S ^b   Rashid, Rezoana ^b   Behniwal, Ajay ^b   Wein, Alan J ^c   Maliski, Sally L ^b   Anger, Jennifer T ^b,d  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BEHAVIOR THERAPY; CLINICAL EVALUATION; FEMALE; GERONTOLOGIST; GROUNDED THEORY; GYNECOLOGIST; HUMAN; INTERVIEW; MEDICAL EXPERT; OVERACTIVE BLADDER; PATIENT CARE; PERCEPTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SYMPTOM ASSESSMENT; TREATMENT OUTCOME; URINE INCONTINENCE; UROLOGIST; VERBAL COMMUNICATION;

ATTITUDE OF HEALTH PERSONNEL; CHRONIC DISEASE; COGNITIVE THERAPY; FEMALE; HUMANS; INTERVIEWS AS TOPIC; QUALITATIVE RESEARCH; TERMINOLOGY AS TOPIC; URINARY BLADDER, OVERACTIVE; UROLOGY;

EID: 84873293121     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2012.09.028     Document Type: Article

References (19)

1. P. Abrams, L. Cardozo, M. Fall Standardisation Subcommittee of the International Continence Society The standardisation of terminology of lower urinary tract function: report from the Standardisation Subcommittee of the International Continence Society Neurourol Urodyn 21 2002 167 178
2. A.J. Wein, and E.S. Rovner Definition and epidemiology of overactive bladder Urology 60 2002 7 12
3. J.G. Blaivas Overactive bladder and the definition of urgency Neurourol Urodyn 26 2007 757 758
4. H. Madersbacher Overactive bladder: a clinical entity or a marketing hype? Eur Urol 47 2005 273 276
5. P.K. Sand, and R. Dmochowski Analysis of the standardisation of terminology of lower urinary tract dysfunction: report from the Standardisation Subcommittee of the International Continence Society Neurourol Urodyn 21 2002 167 178
6. I. Milsom, P. Abrams, and L. Cardozo How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study BJU Int 87 2001 760 766
7. D.E. Irwin, Z.S. Kopp, and B. Agatep Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction BJU Int 108 2011 1132 1138
8. C.P. Vaughan, T.M. Johnson, and M.A. Ala-Lipasti The prevalence of clinically meaningful overactive bladder: bother and quality of life results from the population-based FINNO study Eur Urol 59 2011 629 636
9. M.L. Ganz, A.M. Smalarz, and T.L. Krupski Economic costs of overactive bladder in the United States Urology 75 2010 526 532
10. K. Charmaz "Discovering" chronic illness: using grounded theory Soc Sci Med 30 1990 1161 1172
11. P. Abrams Describing bladder storage function: overactive bladder syndrome and detrusor overactivity Urology 62 2003 28 37
12. P. Abrams, and A.J. Wein The overactive bladder: from basic science to clinical management Urology 50 1997 1 3
13. P. Abrams, and A.J. Wein The overactive bladder and incontinence: definitions and a plea for discussion Neurourol Urodyn 18 1999 413 416
14. A. Wein, and E. Rovner Definition and epidemiology of overactive bladder Urology 60 2002 7 12
15. A. Wein Symptom-based diagnosis of overactive bladder: an overview Can Urol Assoc J 5 2011 S135 S136
16. K.E. Hartmann, M.L. McPheeters, and D.H. Biller Treatment of Overactive Bladder in Women. Evidence Reports/Technology Assessments No. 187 2009 Agency for Healthcare Research and Quality Rockville, MD
17. M. Drake, and P. Abrams Overactive bladder A.J. Wein, L.R. Kavoussi, A.C. Novick, A.W. Partin, C.A. Peters, Campbell-Walsh Urology vol 3 2011 Saunders Elsevier Philadelphia 1947
18. I. Nygaard, T. Chai, and G. Cundiff Summary of research recommendations from the Inaugural AUGS Research Summit Female Pelvic Med Reconstr Surg 17 2011 4 7
19. J.T. Anger, H.A. Nissim, and T.X. Le Women's experience with severe overactive bladder symptoms and treatment: insight revealed from patient focus groups Neurourol Urodyn 30 2011 1295 1299